Skip to main content
PeerJ logoLink to PeerJ
. 2020 Aug 4;8:e9591. doi: 10.7717/peerj.9591

Regional distribution of Christensenellaceae and its associations with metabolic syndrome based on a population-level analysis

Xiang Li 1,#, Zewen Li 1,#, Yan He 1, Pan Li 1, Hongwei Zhou 1,, Nianyi Zeng 1,
Editor: Elliot Lefkowitz
PMCID: PMC7413085  PMID: 32832265

Abstract

The link between the gut microbiota and metabolic syndrome (MetS) has attracted widespread attention. Christensenellaceae was recently described as an important player in human health, while its distribution and relationship with MetS in Chinese population is still unknown. This study sought to observe the association between Christensenellaceae and metabolic indexes in a large sample of residents in South China. A total of 4,781 people from the GGMP project were included, and the fecal microbiota composition of these individuals was characterized by 16S rRNA sequencing and analyzed the relation between Christensenellaceae and metabolism using QIIME (Quantitative Insight Into Microbial Ecology, Version 1.9.1). The results demonstrated that microbial richness and diversity were increased in the group with a high abundance of Christensenellaceae, who showed a greater complexity of the co-occurrence network with other bacteria than residents who lacked Christensenellaceae. The enriched bacterial taxa were predominantly represented by Oscillospira, Ruminococcaceae, RF39, Rikenellaceae and Akkermansia as the Christensenellaceae abundance increased, while the abundances of Veillonella, Fusobacterium and Klebsiella were significantly reduced. Furthermore, Christensenellaceae was negatively correlated with the pathological features of MetS, such as obesity, hypertriglyceridemia and body mass index (BMI). We found reduced levels of lipid biosynthesis and energy metabolism pathways in people with a high abundance of Christensenellaceae, which may explain the negative relationship between body weight and Christensenellaceae. In conclusion, we found a negative correlation between Christensenellaceae and MetS in a large Chinese population and reported the geographical distribution of Christensenellaceae in the GGMP study. The association data from this population-level research support the investigation of strains within Christensenellaceae as potentially beneficial gut microbes.

Keywords: Christensenellaceae, 16S rRNA sequencing, Metabolic syndrome, Human gut microbiota, Bioinformatic analysis

Introduction

Metabolic syndrome (MetS) is a disease that brings together a variety of metabolic disorders. With economic development and the improvement of living standards, the incidence of MetS has also gradually increased, making this disease a global public health problem. MetS is characterized by abdominal obesity, dyslipidemia, hypertension, and elevated blood sugar, and it currently affects approximately 20 to 30% of adults worldwide (Grundy, 2008). There are several factors involved in the development of the disease, including host genetic factors (Kraja et al., 2011), eating habits and sedentary lifestyle (He et al., 2018), but the pathogenesis of MetS has not been fully elucidated.

With technological development, the role of the microbiome in human health has been increasingly emphasized. The gut microbiota impacts a range of human health conditions, including metabolic processes, immune-related diseases and neurological disorders (Integrative HMP Research Network Consortium, 2019; Festi et al., 2014; Fung, Olson & Hsiao, 2017). Studies on MetS and the gut microbiota in mouse models have shown that the development of MetS involves a combination of the gut microbiota, host genes and diet (Ussar et al., 2015; Zmora, Suez & Elinav, 2019). Specific gut microbiota, bacterial metabolic pathways and their interactions with human health are new focuses of microbiome research (Proctor, 2019), and understanding of the microbiome is intended to pave the way for future microbiological therapies (Douillard & De Vos, 2019). An increasing number of studies have reported that probiotics in the intestinal tract can maintain intestinal homeostasis by regulating glucose and lipid metabolism, inhibiting the inflammatory response, and improving metabolic disorders (Lau et al., 2019; Plaza-Díaz et al., 2017; Sanders et al., 2019), thus preventing MetS and related complications.

In this study, we focused on a family of Firmicutes named Christensenellaceae, where the type strain Christensenellaceae minuta was first isolated from the feces of a healthy Japanese man in 2012 and named after the Danish microbiologist Henrik Christensen (Morotomi, Nagai & Watanabe, 2012; Waters & Ley, 2019). Since this family of bacteria was recently isolated, little is known about its biological function other than its association with the host and with other microorganisms. Goodrich et al. (2014) found that Christensenellaceae accounted for 0.01% of human feces from the UK Twins population. In data from China (Kong et al., 2016; Wang et al., 2015), South Korea (Kim et al., 2019) and Italy (Biagi et al., 2016), the bacteria were found to be highly abundant in centenarians. Brooks et al. reported that American females have a higher abundance of Christensenellaceae than American males (Brooks et al., 2018). In addition, a study conducted in Amsterdam showed that the relative abundance of Christensenellaceae is ethnicity specific (Brooks et al., 2018; Deschasaux et al., 2018). These studies demonstrated that age, gender, and ethnicity are associated with the abundance of Christensenellaceae. The relative abundance of Christensenellaceae in the intestine was found to be inversely proportional to body mass index (BMI) (Fu et al., 2015; Goodrich et al., 2014; Oki et al., 2016; Peters et al., 2018b) and exhibited a negative correlation with obesity and inflammatory bowel disease (Braun et al., 2019; Gevers et al., 2014; Imhann et al., 2018).

We previously performed the Guangdong Gut Microbiome Project (GGMP) study, constructing the largest intestinal microbiota database for Eastern countries to date. In the present study, we selected the Christensenellaceae-related population from GGMP to find out the relationship between Christensenellaceae and regional distribution, metabolic index and metabolic diseases. We also focused on the connection between sequential operational taxonomic unit (sub-OTU) (Amir et al., 2017) members of Christensenellaceae and the metabolic index. We also utilized the GGMP dataset to reveal the metabolic pathway signatures of Christensenellaceae. A better understanding of the relationship between MetS and Christensenellaceae may lead to new therapeutic approaches for MetS.

Materials & Methods

Data collection and criteria for MetS

The data used in this analysis from the GGMP were described previously (He et al., 2018b). In brief, 9,172 individuals were investigated, and 6,896 people finished the survey and household sampling (2,276 missing metadata). By further filtering the metadata, some individuals with sequence number less than 10,000 were excluded from this analysis, so a total of 6,879 individuals were retained. The GGMP employs an in-person questionnaire to collect individual metadata. To evaluate how Christensenellaceae members affect the metabolism and gut microbes, we also compiled information on whether the individuals had diabetes, dyslipidemia, and pre-diabetic symptoms.

MetS was diagnosed as described by the Joint Committee for Developing Chinese Guidelines on Prevention and Treatment of Dyslipidemia in adults, based on three of the following five criteria for participants: (1) waist circumference >90 cm (male) or >85 cm (female), (2) fasting blood glucose (FBG) ≥ 6.1 mmol/L (110 mg/dl) or previously diagnosed with diabetes, (3) triglyceride (TG) ≥ 1.7 mmol/L (150 mg/dl), (4) high-density lipoprotein (HDL) <1.04 mmol/L (40 mg/dl), and (5) systolic/diastolic blood pressure (SBP/DBP) ≥ 130/85 mmHg or previously diagnosed with high blood pressure.

Sample collection and DNA extraction

Stool samplers, ice bags and ice boxes were provided to collect and store samples after the questionnaire survey. After defecation, each participant recorded their Bristol stool score and stored the sample in an ice bag. All the samples were stored in a freezer (−18 °C to −20 °C) for less than 3 days and then transported to the research laboratory (Guangdong CDC) in a cold-chain vehicle to maintain a low-temperature environment. Samples were transported and stored at the research laboratory in −80 °C freezers until further processing.

A total of 200 mg of each fecal sample was used for DNA extraction using the Fecal DNA Bead Isolation Kit (Bioeasy, Shenzhen) according to the manufacturer’s instructions. Before the specimens were submitted to laboratory analysis, we prepared external standards to control for potential batch effects because multiple technicians and machines were involved in sample processing. Briefly, fecal samples were collected from three donors. For each donor, the samples were manually homogenized to obtain an even mixture, divided into 200 tubes and stored at −80 °C. All stool samples were processed with identical protocols, including three external standards for each batch. For each DNA sample, the bacterial 16S rRNA gene was amplified with the following barcoded primers (shown from 5′ to 3′): V4F (GTGYCAGCMGCCGCGGTAA) and V4R (GGACTACNVGGGTWTCTAAT) (Walters et al., 2016). The primers contained Illumina adapters and a unique 8-nucleotide barcode. The PCR conditions included an initial denaturation at 94 °C for 5 min; 30 cycles of denaturation at 94 °C for 30 s, annealing at 52 °C for 30 s, and elongation at 72 °C for 45 s; and a final extension at 72 °C for 5 min. The products were submitted for next-generation sequencing on an Illumina HiSeq 2500 platform using 500-cycle version 2 reagent kits (Beijing Genome Institute, BGI, Beijing).

Microbiome bioinformatic analysis

Raw sequence data were managed and analyzed using Quantitative Insights Into Microbial Ecology software (QIIME, version 1.9.1) (Caporaso et al., 2010), and the sequences with Phred quality scores below 20 were then discarded. The method for processing of sequences was identical to that described in our previous reports (He et al., 2018b). PCoA based on unweighted UniFrac distances comparing bacterial community structure of samples between G1 and G2. Permutational multivariate analysis of variance (PERMANOVA) was carried out to measure effect sizes and significance differences in beta diversity. The threshold of statistical significance was set at P < 0.05. We carried out multivariate association analyses with linear modeling (MaAsLin) as described by Morgan et al. (2012) to examine the relationship between sequential taxonomic units and each of the MetS diagnostic factors and several related diseases. Age was used as a confounder, and the false discovery rate was limited to 0.05. The R package (ggtree) (Yu et al., 2018) was used to visualize the evolution tree data after multi-sequence comparison with QIIME. Data plotting and statistical analyses were performed by R (3.2.2) statistical software.

Ethics approval and consent to participate

The present study was approved by the Ethical Review Committee of the Chinese Center for Disease Control and Prevention under approval notice no. 201519-A. Written consent was obtained from all participants.

Statistical analysis

The significance of differences between two groups was resolved by the Wilcoxon rank-sum test. Spearman’s rank correlation test was applied to analyze the correlation between two variables. The chi-square test was utilized to compare the ratios of two groups. P values less than or equal to 0.05 were considered significant. The Benjamini and Hochberg method was used to modulate the P value for multiple hypotheses.

Results

The overall gut Christensenellaceae configuration of people in the GGMP

Exploration of the effects of the gut microbiota requires data from studies performed with a regionalized study design, comprehensive sampling and standardized experimental protocols. The population included in the GGMP has been previously described (He et al., 2018b). In the GGMP project, 6896 individuals were included according to our entry criteria, which followed the guidelines of the Joint Committee for Developing Chinese Guidelines as mentioned in a previous article (He et al., 2018). In the GGMP study, totally 6896 samples were characterized by 16S rRNA gene sequencing, and more than 17,083 quality-filtered sequences were obtained through QIIME analyses.Based on our statistics, the family Christensenellaceae accounted for an average of 0.11% of human fecal bacteria in the residents. Then, we grouped the individuals based on the abundance of Christensenellaceae; in total, 3316 people had no Christensenellaceae in their intestines (Group1, G1), and we selected the upper quartile population as Group2 (G2, n = 1465) according to Christensenellaceae abundance. The abundance of Christensenellaceae in this study was bias distributed, the overall median value was 0, and the maximum value was 15.1%. Statistics found that the average abundance of Christensenellaceae in the G2 group was 0.49%.To characterize the diversity and richness of the bacterial community, the alpha indices, estimated by four different parameters, were analyzed for each sample. As shown in Fig. S1, the diversity and richness estimators in the two cohorts were significantly different. Compared with the G1 subjects, the G2 subjects had a significantly high alpha diversity indexes, such as the Chao1, observed OTU, PD_whole tree and Shannon indexes (p < 0.001 for each). To measure the degree of similarity of the fecal microbial communities, we performed a principal coordinate analysis (Fig. 1A), and we found obvious differences between the two groups (R2 = 0.07184, P = 0.001). Additionally, we applied linear discriminant analysis effect size (LEfSe) (Segata et al., 2011) for quantitative analysis of biomarkers within different cohorts. A total of 20 features had significantly different abundances between G1 and G2(LDA>3) (Fig. 1B). At the genus level, the fecal microbiota of people who lacked Christensenellaceae was enriched with the taxa Proteobacteria, Enterobacteriales, Bacteroidaceae, Lachnospiraceae and Klebsiella, whereas individuals with a high proportion of Christensenellaceae exhibited enrichment of Ruminococcaceae, Mollicutes, RF39, Akkermansia and Rikenellaceae.

Figure 1. Bacterial community structure analysis and sequential operational taxonomic units of Christensenellaceae.

Figure 1

(A) PCoA based on unweighted UniFrac distances comparing bacterial community structure of samples between G1 and G2. Permutational multivariate analysis of variance (PERMANOVA) was carried out to measure effect sizes and significance differences in beta diversity. The threshold of statistical significance was set at P < 0.05. (B) Visualization of taxa meeting a LDA threshold > 3. LEfSe cladogram showed the differential abundant taxa between the two cohorts. Subjects without Christensenellaceae in orange; chris-rich subjects in blue. (C) Sub-OTUs at the level of Christensenellaceae were arranged according to the read number.

To examine the Christensenellaceae components in detail, we analyzed the sub-OTUs at the family level. After chimera removal and quality filtering, a total of 134 different sub-OTUs of Christensenellaceae were identified at the 100% sequence identity level, and eight of them had read counts greater than 1,000 (Fig. 1C). An evolutionary tree was constructed to further observe the evolutionary distance of each sub-OTU and several reference genome (Fig. S1).

The distribution of Christensenellaceae in GGMP

In our survey for the GGMP study, the distribution of Christensenellaceae in Guangdong Province varied based on geographic location. According to the average abundance data, Christensenellaceae is unevenly geographically distributed, with the abundance typically reduced in or near large and economically thriving centers such as Guangzhou (0.08%) and Shenzhen (0.09%). In contrast, Shanwei had the highest abundance (0.22%), followed by Huizhou (0.19%) and Meizhou (0.18%). The abundances in other cities is shown in Fig. 2A. In addition, we collected data on per capita annual income and Christensnellaceae abundance in each region (Fig. 2B). According to the map, the higher the level of urbanization, the lower the abundance of Christensenellaceae in the intestinal tract of urban residents.

Figure 2. The geographical features of Christensenellaceae in different regions in GGMP.

Figure 2

(A) Histogram based on the average abundance of Christensenellaceae in 14 regions of GGMP. City abbreviation is on the X-axis and the abundance value in on the Y-axis. (B) Annual income and Christensenellaceae abundance in 14 regions of GGMP. (C) The prevalence of metabolic syndrome and the average abundance of Christensenellaceae in each region. The blue line represents metabolic syndrome prevalence and the orange line represents average abundance of Christensenellaceae. (D) Prevalence of metabolic syndrome in people with different Christensenellaceae abundance in each area. Light orange represents G1 (n = 3316) and light blue represents G2 (n = 1465).

When the MetS prevalence in different cities was compared, there was a significantly negative correlation between MetS and Christensenellaceae abundance (Fig. 2C). Residents in Zhanjiang, Shanwei, Foshan and Maoming had Christensenellaceae abundances higher than 0.15% in their gut and exhibited a low prevalence of MetS. Similarly, city dwellers in Guangzhou, Shenzhen and Shaoguan had a low Christensenellaceae abundance, and a high proportion of the population exhibited MetS. However, a negative correlation was not observed in residents in Jieyang and Meizhou. Notably, the prevalence of MetS in G2 subjects was lower than that in G1subjects in most regions (Fig. 2D). Moreover, there was a significant difference in the prevalence of MetS in people with different abundances of Christensenellaceae in Qingyuan (p < 0.01) and Shanwei (p < 0.05). Although Christensenellaceae abundance varies in different regions, the negative correlation between MetS and Christensenellaceae is universal.

Christensenellaceae is associated with host metabolic index and MetS status

To explore the relationship between Christensenellaceae abundance and human health, we next assessed how variable the body parameters were in terms of Christensenellaceae richness. We selected 4,781 subjects associated with Christensenellaceae from the GGMP project, and subjects in this study cohort had a wide range of age, BMI and blood test indicators (Table 1). As previously described, we classified the subjects into two categories (G1 and G2) according to the abundance of Christensenellaceae. The differences between the two groups were mainly reflected in the following aspects: age, anthropometric parameters and biochemical criteria (Table 1). Because variations in metabolites could be related to differences in age (Dunn et al., 2015), we reanalyzed the correlation between the indices after adjusting for age. Compared to the G1 group, people rich in Christensenellaceae showed significantly low BMI, waist circumference and waist-to-height ratio (WHtR). The high-value group also showed lower levels of biochemical indices, such as TG, alanine transaminase (ALT) and uric acid (UA), than the non-Christensenellaceae group (Fig. S2). The level of HDL was significantly higher in people with Christensenellaceae, indicating the abundance of Christensenellaceae has a positive correlation with HDL level.

Table 1. Anthropometric parameters and biochemical criterions variations stratified by abundance of Christensenellaceae.

G1-value (n = 3316) G2-value (n = 1465) P-value
Age(years)
Median[SD] 53.0[14.5] 55.0[15.2] <0.001
Sex
Female 1830(55.2%) 824(56.2%) 0.517
Male 1486(44.8%) 641(43.8%)
BMI(kg/m2)
Median[SD] 23.4[3.61] 22.5[3.23] <0.001
Missing 39(1.2%) 27(1.8%)
Waist(cm)
Median[SD] 80.4[10.1] 78.3[9.22] <0.001
Missing 39(1.2%) 27(1.8%)
WHtR
Median[SD] 0.512[0.0651] 0.497[0.0603] <0.001
Missing 39(1.2%) 27(1.8%)
Obesity
Yes 394(11.9%) 92(6.3%) <0.001
No 2883(86.9%) 1346(91.9%)
Missing 39(1.2%) 27(1.8%)
MetS
Yes 739(22.3%) 227(15.5%) <0.001
No 2529(86.4%) 1209(82.5%)
Missing 38(1.1%) 29(2.0%)
Hypertriglyceridemia
Yes 414(12.5%) 99(6.8%) <0.001
No 2864(86.4%) 1339(91.4%)
Missing 38(1.1%) 27(1.8%)
UA(µmol/L)
Median[SD] 330[94.5] 315[87.3] <0.001
Missing 38(1.1%) 27(1.8%)
TG(mmol/L)
Median[SD] 1.15[1.56] 0.9555[1.36] <0.001
Missing 38(1.1%) 27(1.8%)
ALT(U/L)
Median[SD] 16.0[16.5] 14.0[13.7] <0.001
Missing 107(3.2%) 52(3.5%)
Hb(g/L)
Median[SD] 143[21.9] 141[20.3] <0.001
Missing 38(1.1%) 27(1.8%)
HDL(mmol/L)
Median[SD] 1.22[0.520] 1.25[0.435] 0.0155
Missing 40(1.2%) 27(1.8%)

Notes.

SD
standard deviation
BMI
indicates body mass index
WHtR
waist-to-height ratio
UA
uric acid
TG
triglyceride
ALT
alanine transaminase
Hb
hemoglobin
HDL
high density lipoprotein

In addition, we calculated the correlation coefficients between the waist circumference, WHtR, BMI, TG level and other clinical parameters of all subjects to evaluate the connection intensity between the abundance of Christensenellaceae and the host metabolic index (Fig. 3A). We found that waist circumference and WHtR remained significantly decreased in people rich in Christensenellaceae compared to the people who lacked Christensenellaceae. Recently, waist circumference and WHtR were proposed as predictors of the incidence of MetS (Perona et al., 2019; Suliga et al., 2019). Therefore, we measured the prevalence of MetS in individuals with GGMP. People rich in Christensenellaceae had low prevalence of metabolic diseases, including overweight, obesity, fatty liver disease, and hypertriglyceridemia.

Figure 3. Metabolism related index and disease status related to Christensenellaceae.

Figure 3

(A) Heatmap of the association between metabolic index and Christensenellaceae as well as its sOTU. Color depth indicates the pearson correlation coefficients. ***P < 0.001, **P < 0.01, *P < 0.05. (B) The network showed the significant association between Christensenellaceae sub-OTUs and metabolic diseases. The blue arrow represents the negative correlation, and the orange represents positive. The number of significant association was summarized on the edge of network. Mets, metabolic syndrome; FLD, fatty liver disease; HTN, hypertension; USD, urinary system diseases; T2DM, type 2 diabetes.

We also tested for connections between the sequential taxonomic units of Christensenellaceae and the indicators to observe whether the changes in sub-OTUs at the family level of Christensenellaceae are consistent. These top eight sub-OTUs, with reads number greater than 1,000, had the same correlation with each parameter (Fig. 3A). They all had negative correlations with ALT, TG, UA, waist circumference and WHtR. Among the sub-OTUs, sub-OTU3228 had a significantly negative correlation with TG, ALT, UA and BMI. Nevertheless, most of the taxonomic units were positively related to HDL and blood urea nitrogen (BUN).

In addition to morphological indicators and circulating metabolites, we also identified an association between the family Christensenellaceae and metabolic diseases such as fatty liver disease, obesity, hypertriglyceridemia and digestive system disease (Fig. 3B). Moreover, we found that sub-OTU3228, sub-OTU5291, sub-OTU12860, and sub-OTU14698 were negatively correlated with overweight, obesity and hypertriglyceridemia. Although most of the associated taxa were shared across obesity and lipid metabolites, several sequences were predominantly linked to digestive diseases rather than metabolic disorders. Notably, the abundances of sub-OTU3228 and sub-OTU14698 were negatively associated with digestive disorders, while sub-OTU3228 showed a strong positive correlation with the occurrence of diabetes mellitus (T2DM). Besides the above four members, the remaining taxonomic units with read counts greater than 1,000 were not significantly associated with these metabolism-related disorders.

Specific microbial taxa associated with Christensenellaceae

We used co-occurrence network analysis to investigate the interactions among the microbes in the complex intestinal microbiota. After pairwise correlation analysis of the bacteria in all the volunteers’ stool samples, the major bacteria associated with Christensenellaceae in the individuals enrolled in the study are shown in Fig. 4A. Of all the species, the abundances of Veillonella, Ruminococcus, Fusobacterium, and Blautia were most highly negatively related to Christensenellaceae. Additionally, species such as Ralstonia and Klebsiella had a negative correlation with the abundance of Christensenellaceae. In addition, we identified a significant positive association of Christensenellaceae with Oscillospira, Ruminococcaceae, RF39, Rikenellaceae and Akkermansia. Moreover, Lachnospiraceae, Roseburia and Sediminibacterium also showed expected relationship with Christensenellaceae.

Figure 4. Microbial taxa associated with Christensenellaceae.

Figure 4

(A) Co-occurrence network between Christensenellaceae and the relative microbiota. The orange line indicates positive correlation and blue negative correlation. ***P < 0.001, **P < 0.01, *P < 0.05. (B) Matrix Diagram of sub-OTUs within Christensenellaceae and related microbiota. Microbiota that are significantly associated with Christensenellaceae were plotted. The size of the plots represents the strength of the correlation.

The focus was not only on the family level of the microbiota but also on the sub-OTUs of Christensenellaceae. The correlation between sequential taxonomic units of Christensenellaceae and other bacteria was universal. As shown in Fig. 4B, the eight sequences with read counts in excess of a thousand were consistent with the relationships between other bacteria. The four sequences sub-OTU14698, sub-OTU3228, sub-OTU12860, and sub-OTU5219 showed the strongest correlation, and the predominant bacteria in the positive correlation included Oscillospira, Clostridiales, RF39 and Rikenellaceae. Nevertheless, Veillonella, Fusobacterium, Blautia, Megamonas and Streptococcus were negatively associated with these five sub-OTUs. In general, the bacterial network relationship at the sequence level and the family level is basically the same.

Functional properties predicted by PICRUSt

We performed PICRUSt analysis to predict the KEGG functional orthologs of the fecal microbiota metagenomes based on 16S rRNA sequences. Principal component analysis (PCA) showed that the KO profile of the gut microbiota in people with high abundance of Christensenellaceae diverged from that of the gut microbiota of people lacking Christensenellaceae (Fig. S3). 71.2% of the variation within these two groups was captured by the first principal component (PC1). As shown in Fig. 5, broad potential communication pathways were identified between the individuals, including metabolism, cellular process, environmental information process, genetic information process and human disease. The LEfSe algorithm was applied to detect differences in the functional pathways of the microbiota between the two groups. In total, 6 functional orthologs were significantly different in Christensenellaceae-rich people (LDA score>3); the enriched orthologs were nucleotide metabolism; cellular process; ribosome; translation; replication and repair; and genetic information processing. In contrast, the prevalent markers among the controls included those associated with transporters, membrane transport and environmental information processing (Fig. 5). Moreover, several metabolic pathways were abundant in the non-Christensenellaceae group, including those involved in energy metabolism (methane metabolism), lipid metabolism (fatty acid biosynthesis) and carbohydrate metabolism (fructose and mannose metabolism) (Table S1). In terms of metabolic disease, people with Christensenellaceae have a relatively low risk of diabetes mellitus (Table S1). These findings suggest that Christensenellaceae may affect the way in which we metabolize and regulate ponderal growth.

Figure 5. Differential pathways in individuals with different abundance of Christensenellaceae.

Figure 5

G1, LDA score < −3, orange color; G2, LDA > 3, blue color.

Discussion

This study was based on a rigorous experimental design and strict quality control, and fecal samples and host information of 6,896 volunteers were collected in Guangdong Province. The use of 16S rRNA sequencing helped us clearly elucidate the complexity of the gut microbial ecosystem. We could focus not only on the composition and distribution of intestinal bacteria but also on the metabolic functions of these bacteria. Through the integration of these data, we could focus on the associated OTUs classified within the Christensenellaceae family. And we can target these OTUs as a keystone and link the etiology and pathogenesis of MetS to intestinal microorganisms to provide potential therapeutic targets.

First, the present study showed a variation in Christensenellaceae among residents in different areas by comparing the average abundance for each region. Based on our previous research, MetS prevalence was significantly higher in individuals with higher economic status than in those of with lower economic status (He et al., 2018a). As we found that Christensenellaceae is negatively correlated with MetS, it can be explained to some extent that people in economically developed regions have lower intestinal abundance of Christensenellaceae. Moreover, the individual differences in Christensenellaceae may simply be a result of environmental or genetic factors (Waters & Ley, 2019). And our results for large study population showed that the negative correlation between MetS and Christensenellaceae is consistent in most areas.

As previously reported, the abundance of Christensenella, Bifidobacterium and Akkermansia has been recognized as a signature of the gut ecosystem for healthy aging and longevity (Biagi et al., 2016; Derrien, Belzer & De Vos, 2017; Wang et al., 2015). We also found that people with a high abundance of Christensenellaceae were older than those in the control group. Changing functions of the intestine with age may affect the abundance of bacteria.

The microbiota inhabiting the intestinal cavity affects body health by altering the metabolome and regulating the bacterial bioavailability of nutrients in the lumen. (Johnson et al., 2015; Liu et al., 2018; Romano et al., 2015). In this study, we observed a significant association between the gut microbiota and the variation in BMI and blood lipid levels, which is independent of age. We observed that the abundance of Christensenellaceae was significantly related to the individual variance in BMI and to the blood levels of TG and HDL but has not much correlation with low-density lipoprotein (LDL) or total cholesterol (TC) levels. The analysis showed that people with higher Christensenellaceae abundance in their gut had lower BMI and lower TG levels. These results are consistent with the previous report demonstrating that Christensenellaceae abundance was negatively correlated with BMI and triglycerides and positively correlated with HDL levels in the Dutch LifeLines DEEP cohort (n = 893) and reports from other countries (Fu et al., 2015; Peters et al., 2018a; Waters & Ley, 2019). As low HDL levels are one of the criteria of metabolic syndrome (Yang & Wang, 2019). The positive relationship between Christensenellaceae and HDL suggests a potentially beneficial role in metabolism. Therefore, in the complex network of indicators associated with Christensenellaceae, these findings show the negative correlation between Christensenellaceae with the prevalence of MetS.

The microbial interaction network has been considered an important biological factor in the occurrence and progression of metabolic system diseases. We observed significant microbial community changes in people with high abundance of Christensenellaceae, in whom the richness and diversity of the microbial community increased significantly. Our results highlight the positive correlation between Christensenellaceae and Oscillospira, Ruminococcaceae, RF39, Rikenellaceae and Akkermansia (Goodrich et al., 2014), while the bacteria were negatively related to Veillonella, Fusobacterium and Klebsiella. Previous studies have shown that Oscillospira and Ruminococcaceae are positively associated with health and leanness (Konikoff & Gophna, 2016; Zietak et al., 2016). Other noteworthy taxa include Akkermansia, RF39 and Rikenellaceae, which have been experimentally confirmed to be probiotics and are considered beneficial to limit high fat-induced body weight gain. (Alard et al., 2016; Wang et al., 2017). Moreover, previous reports have shown that Fusobacterium and Klebsiella are positively correlated with the levels of cholesterol and LDL and alter lipid metabolism (Fei et al., 2020; Koren et al., 2011). How Christensenellaceae members impact the diversity and structure of the intestinal microbiota is still unclear. Nevertheless, it is plausible that changes in the intestinal niche induced by Christensenellaceae can promote lipid metabolism and contribute to the maintenance of normal body weight.

Our work showed differences in the predicted microbiota function in people with different abundances of Christensenellaceae. Previous reports indicated that obesity markers were typically positively associated with the KEGG categories of fructose metabolism (Hannou et al., 2018) and methane metabolism (Mathur et al., 2013), which are enriched in people who lack Christensenellaceae. However, it’s not a general consistency with the previous result that Methanobacteriaceae increased in G2 group. PICRUSt represents the methane metabolism of the whole gut flora, but the single increased abundance of Methanobacteriaceae does not indicate the overall function. The high abundance of Christensenellaceae in individuals showed decreased fatty acid biosynthesis. Increasing evidence has shown that fatty acid accumulation is significantly associated with metabolic diseases and obesity (Sonnenburg & Bäckhed, 2016). This confirmed the previously observed negative correlation between Christensenellaceae and metabolic indicators. To develop a deeper understanding of MetS progression, further follow-up studies are required to examine the significance of microbial functional variations in body metabolism. Furthermore, metatranscriptomic and metabolomic analyses could be used to elucidate the detailed pathways of gene and metabolite interactions, enhancing the understanding of the effects of intestinal bacteria.

Conclusions

In the present study, we used multivariate association analyses to explore the association between Christensenellaceae and metabolic indexes in nearly 5,000 participants in South China. Based on the results, Christensenellaceae is related to a low risk of MetS and obesity, showing similarities to results obtained in Western populations. In addition, significant correlations were found between Christensenellaceae and other intestinal bacteria through analysis of the bacterial network. The bacteria that were positively correlated with Christensenellaceae were mainly beneficial bacteria that had been identified previously, while some pathogenic bacteria were negatively correlated with Christensenellaceae. Finally, PICRUSt was applied to analyze the pathway differences caused by Christensenellaceae, which provided bioinformatics evidence for predicting the correlation between Christensenellaceae and metabolic alterations in the gut microbiota community. However, the underlying mechanisms through which Christensenellaceae members regulate host metabolism need to be explored.

Supplemental Information

Figure S1. Alpha-diversity between two groups and evolutionary tree of sOTU.

(A-D) Alpha-diversity index of the gut microbiota in two groups. Chao1, observed_OTUs, PD_whole tree and Shannon indices were compared between G1 (n=3316) and G2 (n=1465), p < 0.001. (E) Evolutionary relationships between 8 sequential taxonomic units with reading number more than 1000 and several reference genomes of 16S rRNA V4.

DOI: 10.7717/peerj.9591/supp-1
Figure S2. Metabolic related parameters in two groups with different abundance of Christensenellaceae.

*** p < 0.001, ** p < 0.01, * p < 0.05

DOI: 10.7717/peerj.9591/supp-2
Figure S3. Principal Components Analysis (PCA) comparing the KEGG orthology profiles of two groups.
DOI: 10.7717/peerj.9591/supp-3
Table S1. Metabolic pathways between Q1 and Q4.
DOI: 10.7717/peerj.9591/supp-4
Table S2. Metadata of the this manuscript.
DOI: 10.7717/peerj.9591/supp-5
Table S3. 16S rRNA V4 Sequences of sub-OTUs within Christensenellaceae.
DOI: 10.7717/peerj.9591/supp-6

Acknowledgments

We acknowledge the contributions of the 308 local CDC investigators and registered nurses, who helped with collection point maintenance and metadata and stool sample collection. We thank all the volunteers who participated in this project.

Funding Statement

This work was supported by the National Natural Science Foundation of China (No. 81925026). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Contributor Information

Hongwei Zhou, Email: hzhou@smu.edu.cn.

Nianyi Zeng, Email: zengny1@i.smu.edu.cn.

Additional Information and Declarations

Competing Interests

The authors declare there are no competing interests.

Author Contributions

Xiang Li conceived and designed the experiments, performed the experiments, analyzed the data, prepared figures and/or tables, authored or reviewed drafts of the paper, and approved the final draft.

Zewen Li conceived and designed the experiments, performed the experiments, analyzed the data, prepared figures and/or tables, and approved the final draft.

Yan He analyzed the data, authored or reviewed drafts of the paper, and approved the final draft.

Pan Li analyzed the data, prepared figures and/or tables, and approved the final draft.

Hongwei Zhou and Nianyi Zeng conceived and designed the experiments, authored or reviewed drafts of the paper, and approved the final draft.

Human Ethics

The following information was supplied relating to ethical approvals (i.e., approving body and any reference numbers):

The present study was approved by the Ethical Review Committee of the Chinese Center for Disease Control and Prevention under approval notice No. 201519-A. Written consent was obtained from all participants.

Data Availability

The following information was supplied regarding data availability:

The collated data of this analysis are available as Table S2.

The raw sequence data for the 16S rRNA gene are available from the European Nucleotide Archive: PRJEB18535.

The bioinformatics code used for raw data processing is available at Github: https://github.com/SMUJYYXB/GGMP.

References

  • Alard et al. (2016).Alard J, Lehrter V, Rhimi M, Mangin I, Peucelle V, Abraham A-L, Mariadassou M, Maguin E, Waligora-Dupriet A-J, Pot B, Wolowczuk I, Grangette C. Beneficial metabolic effects of selected probiotics on diet-induced obesity and insulin resistance in mice are associated with improvement of dysbiotic gut microbiota. Environmental Microbiology. 2016;18:1484–1497. doi: 10.1111/1462-2920.13181. [DOI] [PubMed] [Google Scholar]
  • Amir et al. (2017).Amir A, McDonald D, Navas-Molina JA, Kopylova E, Morton JT, Zech Xu Z, Kightley EP, Thompson LR, Hyde ER, Gonzalez A, Knight R. Deblur rapidly resolves single-nucleotide community sequence patterns. mSystems. 2017;2:e00191-16. doi: 10.1128/mSystems.00191-16. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • Biagi et al. (2016).Biagi E, Franceschi C, Rampelli S, Severgnini M, Ostan R, Turroni S, Consolandi C, Quercia S, Scurti M, Monti D, Capri M, Brigidi P, Candela M. Gut microbiota and extreme longevity. Current Biology. 2016;26:1480–1485. doi: 10.1016/j.cub.2016.04.016. [DOI] [PubMed] [Google Scholar]
  • Braun et al. (2019).Braun T, Di Segni A, BenShoshan M, Neuman S, Levhar N, Bubis M, Picard O, Sosnovski K, Efroni G, Farage Barhom S, Glick Saar E, Lahad A, Weiss B, Yablecovitch D, Lahat A, Eliakim R, Kopylov U, Ben-Horin S, Haberman Y. Individualized dynamics in the gut microbiota precede crohn’s disease flares. The American Journal of Gastroenterology. 2019;114:1142–1151. doi: 10.14309/ajg.0000000000000136. [DOI] [PubMed] [Google Scholar]
  • Brooks et al. (2018).Brooks AW, Priya S, Blekhman R, Bordenstein SR. Gut microbiota diversity across ethnicities in the United States. PLOS Biology. 2018;16:e2006842. doi: 10.1371/journal.pbio.2006842. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • Caporaso et al. (2010).Caporaso JG, Kuczynski J, Stombaugh J, Bittinger K, Bushman FD, Costello EK, Fierer N, Peña AG, Goodrich JK, Gordon JI, Huttley GA, Kelley ST, Knights D, Koenig JE, Ley RE, Lozupone CA, McDonald D, Muegge BD, Pirrung M, Reeder J, Sevinsky JR, Turnbaugh PJ, Walters WA, Widmann J, Yatsunenko T, Zaneveld J, Knight R. QIIME allows analysis of high-throughput community sequencing data. Nature Methods. 2010;7:335–336. doi: 10.1038/nmeth.f.303. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • Derrien, Belzer & De Vos (2017).Derrien M, Belzer C, De Vos WM. Akkermansia muciniphila and its role in regulating host functions. Microbial Pathogenesis. 2017;106:171–181. doi: 10.1016/j.micpath.2016.02.005. [DOI] [PubMed] [Google Scholar]
  • Deschasaux et al. (2018).Deschasaux M, Bouter KE, Prodan A, Levin E, Groen AK, Herrema H, Tremaroli V, Bakker GJ, Attaye I, Pinto-Sietsma S-J, Van Raalte DH, Snijder MB, Nicolaou M, Peters R, Zwinderman AH, Bäckhed F, Nieuwdorp M. Depicting the composition of gut microbiota in a population with varied ethnic origins but shared geography. Nature Medicine. 2018;24:1526–1531. doi: 10.1038/s41591-018-0160-1. [DOI] [PubMed] [Google Scholar]
  • Douillard & De Vos (2019).Douillard FP, De Vos WM. Biotechnology of health-promoting bacteria. Biotechnology Advances. 2019;37 doi: 10.1016/j.biotechadv.2019.03.008. Article 107369. [DOI] [PubMed] [Google Scholar]
  • Dunn et al. (2015).Dunn WB, Lin W, Broadhurst D, Begley P, Brown M, Zelena E, Vaughan AA, Halsall A, Harding N, Knowles JD, Francis-McIntyre S, Tseng A, Ellis DI, O’Hagan S, Aarons G, Benjamin B, Chew-Graham S, Moseley C, Potter P, Winder CL, Potts C, Thornton P, McWhirter C, Zubair M, Pan M, Burns A, Cruickshank JK, Jayson GC, Purandare N, Wu FCW, Finn JD, Haselden JN, Nicholls AW, Wilson ID, Goodacre R, Kell DB. Molecular phenotyping of a UK population: defining the human serum metabolome. Metabolomics. 2015;11:9–26. doi: 10.1007/s11306-014-0707-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • Fei et al. (2020).Fei N, Bruneau A, Zhang X, Wang R, Wang J, Rabot S, Gérard P, Zhao L. Endotoxin producers overgrowing in human gut microbiota as the causative agents for nonalcoholic fatty liver disease. MBio. 2020;11 doi: 10.1128/mBio.03263-19. Article 03263-19. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • Festi et al. (2014).Festi D, Schiumerini R, Eusebi LH, Marasco G, Taddia M, Colecchia A. Gut microbiota and metabolic syndrome. World Journal of Gastroenterology. 2014;20:16079–16094. doi: 10.3748/wjg.v20.i43.16079. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • Fu et al. (2015).Fu J, Bonder MJ, Cenit MC, Tigchelaar EF, Maatman A, Dekens JAM, Brandsma E, Marczynska J, Imhann F, Weersma RK, Franke L, Poon TW, Xavier RJ, Gevers D, Hofker MH, Wijmenga C, Zhernakova A. The gut microbiome contributes to a substantial proportion of the variation in blood lipids. Circulation Research. 2015;117:817–824. doi: 10.1161/CIRCRESAHA.115.306807. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • Fung, Olson & Hsiao (2017).Fung TC, Olson CA, Hsiao EY. Interactions between the microbiota, immune and nervous systems in health and disease. Nature Neuroscience. 2017;20:145–155. doi: 10.1038/nn.4476. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • Gevers et al. (2014).Gevers D, Kugathasan S, Denson LA, Vázquez-Baeza Y, Treuren WVan, Ren B, Schwager E, Knights D, Song SJ, Yassour M, Morgan XC, Kostic AD, Luo C, González A, McDonald D, Haberman Y, Walters T, Baker S, Rosh J, Stephens M, Heyman M, Markowitz J, Baldassano R, Griffiths A, Sylvester F, Mack D, Kim S, Crandall W, Hyams J, Huttenhower C, Knight R, Xavier RJ. The treatment-naive microbiome in new-onset Crohn’s disease. Cell Host & Microbe. 2014;15:382–392. doi: 10.1016/j.chom.2014.02.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • Goodrich et al. (2014).Goodrich JK, Waters JL, Poole AC, Sutter JL, Koren O, Blekhman R, Beaumont M, Van Treuren W, Knight R, Bell JT, Spector TD, Clark AG, Ley RE. Human genetics shape the gut microbiome. Cell. 2014;159:789–799. doi: 10.1016/j.cell.2014.09.053. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • Grundy (2008).Grundy SM. Metabolic syndrome pandemic. Arteriosclerosis, Thrombosis, and Vascular Biology. 2008;28:629–636. doi: 10.1161/ATVBAHA.107.151092. [DOI] [PubMed] [Google Scholar]
  • Hannou et al. (2018).Hannou SA, Haslam DE, McKeown NM, Herman MA. Fructose metabolism and metabolic disease. Journal of Clinical Investigation. 2018;128:545–555. doi: 10.1172/JCI96702. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • He et al. (2018a).He Y, Wu W, Wu S, Zheng H-M, Li P, Sheng H-F, Chen M-X, Chen Z-H, Ji G-Y, Zheng Z-D-X, Mujagond P, Chen X-J, Rong Z-H, Chen P, Lyu L-Y, Wang X, Xu J-B, Wu C-B, Yu N, Xu Y-J, Yin J, Raes J, Ma W-J, Zhou H-W. Linking gut microbiota, metabolic syndrome and economic status based on a population-level analysis. Microbiome. 2018a;6 doi: 10.1186/s40168-018-0557-6. Article 172(2018) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • He et al. (2018b).He Y, Wu W, Zheng H-M, Li P, McDonald D, Sheng H-F, Chen M-X, Chen Z-H, Ji G-Y, Zheng Z-D-X, Mujagond P, Chen X-J, Rong Z-H, Chen P, Lyu L-Y, Wang X, Wu C-B, Yu N, Xu Y-J, Yin J, Raes J, Knight R, Ma W-J, Zhou H-W. Regional variation limits applications of healthy gut microbiome reference ranges and disease models. Nature Medicine. 2018b;24:1532–1535. doi: 10.1038/s41591-018-0164-x. [DOI] [PubMed] [Google Scholar]
  • Imhann et al. (2018).Imhann F, Vich Vila A, Bonder MJ, Fu J, Gevers D, Visschedijk MC, Spekhorst LM, Alberts R, Franke L, Van Dullemen HM, Ter Steege RWF, Huttenhower C, Dijkstra G, Xavier RJ, Festen EAM, Wijmenga C, Zhernakova A, Weersma RK. Interplay of host genetics and gut microbiota underlying the onset and clinical presentation of inflammatory bowel disease. Gut. 2018;67:108–119. doi: 10.1136/gutjnl-2016-312135. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • Integrative HMP Research Network Consortium (2019).Integrative HMP (iHMP) Research Network Consortium The integrative human microbiome project. Nature. 2019;569:641–648. doi: 10.1038/s41586-019-1238-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • Johnson et al. (2015).Johnson CH, Dejea CM, Edler D, Hoang LT, Santidrian AF, Felding BH, Ivanisevic J, Cho K, Wick EC, Hechenbleikner EM, Uritboonthai W, Goetz L, Casero RA, Pardoll DM, White JR, Patti GJ, Sears CL, Siuzdak G. Metabolism links bacterial biofilms and colon carcinogenesis. Cell Metabolism. 2015;21:891–897. doi: 10.1016/j.cmet.2015.04.011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • Kim et al. (2019).Kim B-S, Choi CW, Shin H, Jin S-P, Bae J-S, Han M, Seo EY, Chun J, Chung JH. Comparison of the gut microbiota of centenarians in longevity villages of South Korea with those of other age groups. Journal of Microbiology and Biotechnology. 2019;29:429–440. doi: 10.4014/jmb.1811.11023. [DOI] [PubMed] [Google Scholar]
  • Kong et al. (2016).Kong F, Hua Y, Zeng B, Ning R, Li Y, Zhao J. Gut microbiota signatures of longevity. Current Biology. 2016;26:R832–R833. doi: 10.1016/j.cub.2016.08.015. [DOI] [PubMed] [Google Scholar]
  • Konikoff & Gophna (2016).Konikoff T, Gophna U. Oscillospira: a central, enigmatic component of the human gut microbiota. Trends in Microbiology. 2016;24:523–524. doi: 10.1016/j.tim.2016.02.015. [DOI] [PubMed] [Google Scholar]
  • Koren et al. (2011).Koren O, Spor A, Felin J, Fåk F, Stombaugh J, Tremaroli V, Behre CJ, Knight R, Fagerberg B, Ley RE, Bäckhed F. Human oral, gut, and plaque microbiota in patients with atherosclerosis. Proceedings of the National Academy of Sciences of the United States of America. 2011;108(Suppl 1):4592–4598. doi: 10.1073/pnas.1011383107. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • Kraja et al. (2011).Kraja AT, Vaidya D, Pankow JS, Goodarzi MO, Assimes TL, Kullo IJ, Sovio U, Mathias RA, Sun YV, Franceschini N, Absher D, Li G, Zhang Q, Feitosa MF, Glazer NL, Haritunians T, Hartikainen A-L, Knowles JW, North KE, Iribarren C, Kral B, Yanek L, O’Reilly PF, McCarthy MI, Jaquish C, Couper DJ, Chakravarti A, Psaty BM, Becker LC, Province MA, Boerwinkle E, Quertermous T, Palotie L, Jarvelin M-R, Becker DM, Kardia SLR, Rotter JI, Chen Y-DI, Borecki IB. A bivariate genome-wide approach to metabolic syndrome: STAMPEED consortium. Diabetes. 2011;60:1329–1339. doi: 10.2337/db10-1011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • Lau et al. (2019).Lau E, Neves JS, Ferreira-Magalhães M, Carvalho D, Freitas P. Probiotic ingestion, obesity, and metabolic-related disorders: results from NHANES, 1999-2014. Nutrients. 2019;11 doi: 10.3390/nu11071482. Article 11071482. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • Liu et al. (2018).Liu Z, Bruins ME, Ni L, Vincken J-P. Green and black tea phenolics: bioavailability, transformation by colonic microbiota, and modulation of colonic microbiota. Journal of Agricultural and Food Chemistry. 2018;66:8469–8477. doi: 10.1021/acs.jafc.8b02233. [DOI] [PubMed] [Google Scholar]
  • Mathur et al. (2013).Mathur R, Amichai M, Chua KS, Mirocha J, Barlow GM, Pimentel M. Methane and hydrogen positivity on breath test is associated with greater body mass index and body fat. The Journal of Clinical Endocrinology and Metabolism. 2013;98:E698–E702. doi: 10.1210/jc.2012-3144. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • Morgan et al. (2012).Morgan XC, Tickle TL, Sokol H, Gevers D, Devaney KL, Ward DV, Reyes JA, Shah SA, LeLeiko N, Snapper SB, Bousvaros A, Korzenik J, Sands BE, Xavier RJ, Huttenhower C. Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment. Genome Biology. 2012;13:R79. doi: 10.1186/gb-2012-13-9-r79. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • Morotomi, Nagai & Watanabe (2012).Morotomi M, Nagai F, Watanabe Y. Description of Christensenella minuta gen. nov. sp. nov. isolated from human faeces, which forms a distinct branch in the order Clostridiales, and proposal of Christensenellaceae fam. nov. International Journal of Systematic and Evolutionary Microbiology. 2012;62:144–149. doi: 10.1099/ijs.0.026989-0. [DOI] [PubMed] [Google Scholar]
  • Oki et al. (2016).Oki K, Toyama M, Banno T, Chonan O, Benno Y, Watanabe K. Comprehensive analysis of the fecal microbiota of healthy Japanese adults reveals a new bacterial lineage associated with a phenotype characterized by a high frequency of bowel movements and a lean body type. BMC Microbiology. 2016;16:284. doi: 10.1186/s12866-016-0898-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • Perona et al. (2019).Perona JS, Schmidt Rio-Valle J, Ramírez-Vélez R, Correa-Rodríguez M, Fernández-Aparicio Á, González-Jiménez E. Waist circumference and abdominal volume index are the strongest anthropometric discriminators of metabolic syndrome in Spanish adolescents. European Journal of Clinical Investigation. 2019;49:e13060. doi: 10.1111/eci.13060. [DOI] [PubMed] [Google Scholar]
  • Peters et al. (2018a).Peters BA, Shapiro JA, Church TR, Miller G, Trinh-Shevrin C, Yuen E, Friedlander C, Hayes RB, Ahn J. A taxonomic signature of obesity in a large study of American adults. Scientific Reports. 2018a;8:9749. doi: 10.1038/s41598-018-28126-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • Peters et al. (2018b).Peters U, Suratt BT, Bates JHT, Dixon AE. Beyond BMI: obesity and Lung Disease. Chest. 2018b;153:702–709. doi: 10.1016/j.chest.2017.07.010. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • Plaza-Díaz et al. (2017).Plaza-Díaz J, Ruiz-Ojeda FJ, Vilchez-Padial LM, Gil A. Evidence of the anti-inflammatory effects of probiotics and synbiotics in intestinal chronic diseases. Nutrients. 2017;9 doi: 10.3390/nu9060555. Article 9060555. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • Proctor (2019).Proctor L. Priorities for the next 10 years of human microbiome research. Nature. 2019;569:623–625. doi: 10.1038/d41586-019-01654-0. [DOI] [PubMed] [Google Scholar]
  • Romano et al. (2015).Romano KA, Vivas EI, Amador-Noguez D, Rey FE. Intestinal microbiota composition modulates choline bioavailability from diet and accumulation of the proatherogenic metabolite trimethylamine-N-oxide. MBio. 2015;6:e02481. doi: 10.1128/mBio.02481-14. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • Sanders et al. (2019).Sanders ME, Merenstein DJ, Reid G, Gibson GR, Rastall RA. Probiotics and prebiotics in intestinal health and disease: from biology to the clinic. Nature Reviews Gastroenterology & Hepatology. 2019;16:605–616. doi: 10.1038/s41575-019-0173-3. [DOI] [PubMed] [Google Scholar]
  • Segata et al. (2011).Segata N, Izard J, Waldron L, Gevers D, Miropolsky L, Garrett WS, Huttenhower C. Metagenomic biomarker discovery and explanation. Genome Biology. 2011;12:R60. doi: 10.1186/gb-2011-12-6-r60. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • Sonnenburg & Bäckhed (2016).Sonnenburg JL, Bäckhed F. Diet-microbiota interactions as moderators of human metabolism. Nature. 2016;535:56–64. doi: 10.1038/nature18846. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • Suliga et al. (2019).Suliga E, Ciesla E, Głuszek-Osuch M, Rogula T, Głuszek S, Kozieł D. The usefulness of anthropometric indices to identify the risk of metabolic syndrome. Nutrients. 2019;11 doi: 10.3390/nu11112598. Article 11112598. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • Ussar et al. (2015).Ussar S, Griffin NW, Bezy O, Fujisaka S, Vienberg S, Softic S, Deng L, Bry L, Gordon JI, Kahn CR. Interactions between gut microbiota, host genetics and diet modulate the predisposition to obesity and metabolic syndrome. Cell Metabolism. 2015;22:516–530. doi: 10.1016/j.cmet.2015.07.007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • Walters et al. (2016).Walters W, Hyde ER, Berg-Lyons D, Ackermann G, Humphrey G, Parada A, Gilbert JA, Jansson JK, Caporaso JG, Fuhrman JA, Apprill A, Knight R. Improved bacterial 16S rRNA gene (V4 and V4-5) and fungal internal transcribed spacer marker gene primers for microbial community surveys. mSystems. 2016;1 doi: 10.1128/mSystems.00009-15. Article 00009-15. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • Wang et al. (2015).Wang F, Yu T, Huang G, Cai D, Liang X, Su H, Zhu Z, Li D, Yang Y, Shen P, Mao R, Yu L, Zhao M, Li Q. Gut microbiota community and its assembly associated with age and diet in chinese centenarians. Journal of Microbiology and Biotechnology. 2015;25:1195–1204. doi: 10.4014/jmb.1410.10014. [DOI] [PubMed] [Google Scholar]
  • Wang et al. (2017).Wang L, Jacobs JP, Lagishetty V, Yuan PQ, Wu SV, Million M, Reeve Jr JR, Pisegna JR, Tache Y. High-protein diet improves sensitivity to cholecystokinin and shifts the cecal microbiome without altering brain inflammation in diet-induced obesity in rats. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology. 2017;313:R473–R486. doi: 10.1152/ajpregu.00105.2017. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • Waters & Ley (2019).Waters JL, Ley RE. The human gut bacteria Christensenellaceae are widespread, heritable, and associated with health. BMC Biology. 2019;17:83. doi: 10.1186/s12915-019-0699-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • Yang & Wang (2019).Yang X, Wang J. The role of metabolic syndrome in endometrial cancer: a review. Frontiers in Oncology. 2019;9 doi: 10.3389/fonc.2019.00744. Article 744. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • Yu et al. (2018).Yu G, Lam TT-Y, Zhu H, Guan Y. Two methods for mapping and visualizing associated data on phylogeny using Ggtree. Molecular Biology and Evolution. 2018;35:3041–3043. doi: 10.1093/molbev/msy194. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • Zietak et al. (2016).Ziętak M, Kovatcheva-Datchary P, Markiewicz LH, Ståhlman M, Kozak LP, Bäckhed F. Altered microbiota contributes to reduced diet-induced obesity upon cold exposure. Cell Metabolism. 2016;23:1216–1223. doi: 10.1016/j.cmet.2016.05.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • Zmora, Suez & Elinav (2019).Zmora N, Suez J, Elinav E. You are what you eat: diet, health and the gut microbiota. Nature Reviews Gastroenterology & Hepatology. 2019;16:35–56. doi: 10.1038/s41575-018-0061-2. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Figure S1. Alpha-diversity between two groups and evolutionary tree of sOTU.

(A-D) Alpha-diversity index of the gut microbiota in two groups. Chao1, observed_OTUs, PD_whole tree and Shannon indices were compared between G1 (n=3316) and G2 (n=1465), p < 0.001. (E) Evolutionary relationships between 8 sequential taxonomic units with reading number more than 1000 and several reference genomes of 16S rRNA V4.

DOI: 10.7717/peerj.9591/supp-1
Figure S2. Metabolic related parameters in two groups with different abundance of Christensenellaceae.

*** p < 0.001, ** p < 0.01, * p < 0.05

DOI: 10.7717/peerj.9591/supp-2
Figure S3. Principal Components Analysis (PCA) comparing the KEGG orthology profiles of two groups.
DOI: 10.7717/peerj.9591/supp-3
Table S1. Metabolic pathways between Q1 and Q4.
DOI: 10.7717/peerj.9591/supp-4
Table S2. Metadata of the this manuscript.
DOI: 10.7717/peerj.9591/supp-5
Table S3. 16S rRNA V4 Sequences of sub-OTUs within Christensenellaceae.
DOI: 10.7717/peerj.9591/supp-6

Data Availability Statement

The following information was supplied regarding data availability:

The collated data of this analysis are available as Table S2.

The raw sequence data for the 16S rRNA gene are available from the European Nucleotide Archive: PRJEB18535.

The bioinformatics code used for raw data processing is available at Github: https://github.com/SMUJYYXB/GGMP.


Articles from PeerJ are provided here courtesy of PeerJ, Inc

RESOURCES